{
    "info": {
        "nct_id": "NCT06770764",
        "official_title": "A Phase 1/1b, Multicenter, Open-label, Dose Escalation and Expansion Study Evaluating the Safety, Pharmacodynamics, and Pharmacokinetics of ODC-IL2 Administered Via Intravenous Infusion in Adult Patients With Advanced or Metastatic Solid Tumors",
        "inclusion_criteria": "Each patient must meet all the following criteria to participate in the study:\n\n1. Histologically or cytologically confirmed advanced or metastatic solid tumors, for which no other standard treatment is available or appropriate, or for which the Trutino Biosciences Protocol #: TRT-ODC-IL2-001 Version: 1.0 Date: 20 September 2024 standard of care is refused by the patient due to tolerability or the Investigator believes the patient will not tolerate standard-of-care therapy\n2. Advanced or metastatic tumors measurable per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria;\n3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1;\n4. Life expectancy of at least 3 months;\n5. Age ≥ 18 years;\n6. Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent\n7. Acceptable liver function:\n\n   * Bilirubin ≤ 1.5 times upper limit of normal (ULN) or ≤ 5 × institutional ULN for patients who have serum bilirubin increases due to underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia).\n   * Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)\n8. Acceptable renal function:\n\n   • Calculated creatinine clearance ≥ 50 mL/min using the Cockcroft-Gault equation.\n9. Acceptable hematologic status:\n\n   * Absolute neutrophil count ≥ 1500 cells/mm3\n   * Platelet count ≥ 75,000 (plt/mm3)\n   * Hemoglobin ≥ 9 g/dL\n10. A negative serum pregnancy test (if a woman of childbearing potential);\n11. Women of childbearing potential (WOCBP) and men with WOCBP partners must agree to use adequate contraception (hormonal method of birth control; intrauterine devices or abstinence) prior to study entry, for the duration of study participation and for 4 months after the last dose of study drug. Should a female trial participant or a female partner of a male trial participant become pregnant or suspect she is pregnant during the study, the Investigator must be informed immediately.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. New York Heart Association Class III or IV, cardiac disease, myocardial infarction within the past 6 months, unstable arrhythmia, or evidence of ischemia on electrocardiogram (ECG)\n2. Have a corrected QT interval (using Fridericia's correction formula) (QTcF) of > 470 msec\n3. Active, uncontrolled bacterial, viral, or fungal infections, requiring systemic therapy\n4. Known active brain metastases; patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks) and without the requirement for treatment with corticosteroids in prior 3 weeks may be considered for enrollment after discussion with the Medical Monitor\n5. History of prior organ transplant\n6. Conditions requiring systemic treatment with corticosteroids or any other form of immunosuppressive therapy within 7 days prior to start of study drug.\n7. History of autoimmune diseases requiring systemic immunosuppressive therapy in the last 2 years\n8. Pregnant or nursing women.\n9. Treatment with radiation therapy, major surgery, chemotherapy, or investigational therapy within 4 weeks prior to study entry (6 weeks for nitrosoureas or mitomycin C). Radiation for palliation of pain is allowed within 1 week prior to study entry, but the lesion should not be selected as a target lesion for RECIST analysis.\n10. Unwillingness or inability to comply with procedures required in this protocol\n11. Known active infection with human immunodeficiency virus (HIV), human T-cell leukemia virus, type 1 (HTLV-1), hepatitis B virus (HBV), or hepatitis C virus (HCV)\n\n    * Patients with a history of hepatitis B or C are allowed if HBV DNA or HCV RNA are undetectable\n    * Active infection with HIV and CD4+ T-cell count <350/μL. Patients not on established anti-retroviral therapy for at least 4 weeks and having a detectable HIV viral load\n12. Serious uncontrolled nonmalignant disease (e.g., renal failure, liver failure, or other conditions) that could compromise protocol objectives in the opinion of the investigator and/or the sponsor\n13. Prior treatment with an IL-2 targeted treatment, unless given as a part of a tumor infiltrating lymphocyte treatment combination;\n14. Known sensitivity to IL-2 or any of the excipients in ODC-IL2;\n15. Active treatment with heparin or heparin-related therapies, unless the patient can be transitioned to a non-heparin treatment for the clinical condition with an adequate washout prior to enrollment in the study.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Each patient must meet all the following criteria to participate in the study:",
                "criterions": []
            },
            "logical_structure": {
                "and_criteria": []
            }
        },
        {
            "identified_line": {
                "line": "7. Acceptable liver function:",
                "criterions": [
                    {
                        "exact_snippets": "Acceptable liver function",
                        "criterion": "liver function",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Acceptable liver function",
                        "criterion": "liver function",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "9. Acceptable hematologic status:",
                "criterions": [
                    {
                        "exact_snippets": "Acceptable hematologic status",
                        "criterion": "hematologic status",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Acceptable hematologic status",
                        "criterion": "hematologic status",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "acceptable"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                "criterions": [
                    {
                        "exact_snippets": "Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "written",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "IRB/EC-approved",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "written",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Signed, written Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "IRB/EC-approved",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "10. A negative serum pregnancy test (if a woman of childbearing potential);",
                "criterions": [
                    {
                        "exact_snippets": "A negative serum pregnancy test (if a woman of childbearing potential)",
                        "criterion": "serum pregnancy test",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    },
                    {
                        "exact_snippets": "if a woman of childbearing potential",
                        "criterion": "sex and reproductive potential",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "if a woman of childbearing potential",
                        "criterion": "sex and reproductive potential",
                        "requirement": {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "and_criteria": [
                        {
                            "exact_snippets": "if a woman of childbearing potential",
                            "criterion": "sex and reproductive potential",
                            "requirement": {
                                "requirement_type": "sex",
                                "expected_value": "female"
                            }
                        },
                        {
                            "exact_snippets": "if a woman of childbearing potential",
                            "criterion": "sex and reproductive potential",
                            "requirement": {
                                "requirement_type": "childbearing potential",
                                "expected_value": true
                            }
                        }
                    ]
                },
                "then_criteria": {
                    "exact_snippets": "A negative serum pregnancy test (if a woman of childbearing potential)",
                    "criterion": "serum pregnancy test",
                    "requirement": {
                        "requirement_type": "result",
                        "expected_value": "negative"
                    }
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "8. Acceptable renal function:",
                "criterions": [
                    {
                        "exact_snippets": "Acceptable renal function",
                        "criterion": "renal function",
                        "requirement": {
                            "requirement_type": "acceptability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Acceptable renal function",
                        "criterion": "renal function",
                        "requirement": {
                            "requirement_type": "acceptability",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Life expectancy of at least 3 months;",
                "criterions": [
                    {
                        "exact_snippets": "Life expectancy of at least 3 months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Life expectancy of at least 3 months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1;",
                "criterions": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "2. Have a corrected QT interval (using Fridericia's correction formula) (QTcF) of > 470 msec",
                "criterions": [
                    {
                        "exact_snippets": "corrected QT interval (using Fridericia's correction formula) (QTcF) of > 470 msec",
                        "criterion": "corrected QT interval (QTcF)",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "msec"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "corrected QT interval (using Fridericia's correction formula) (QTcF) of > 470 msec",
                        "criterion": "corrected QT interval (QTcF)",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "msec"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "14. Known sensitivity to IL-2 or any of the excipients in ODC-IL2;",
                "criterions": [
                    {
                        "exact_snippets": "Known sensitivity to IL-2",
                        "criterion": "sensitivity to IL-2",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known sensitivity to ... any of the excipients in ODC-IL2",
                        "criterion": "sensitivity to excipients in ODC-IL2",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Known sensitivity to IL-2",
                        "criterion": "sensitivity to IL-2",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known sensitivity to ... any of the excipients in ODC-IL2",
                        "criterion": "sensitivity to excipients in ODC-IL2",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "12. Serious uncontrolled nonmalignant disease (e.g., renal failure, liver failure, or other conditions) that could compromise protocol objectives in the opinion of the investigator and/or the sponsor",
                "criterions": [
                    {
                        "exact_snippets": "Serious uncontrolled nonmalignant disease (e.g., renal failure, liver failure, or other conditions)",
                        "criterion": "nonmalignant disease",
                        "requirement": {
                            "requirement_type": "seriousness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Serious uncontrolled nonmalignant disease (e.g., renal failure, liver failure, or other conditions)",
                        "criterion": "nonmalignant disease",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "renal failure",
                        "criterion": "renal failure",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "liver failure",
                        "criterion": "liver failure",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Serious uncontrolled nonmalignant disease (e.g., renal failure, liver failure, or other conditions)",
                                "criterion": "nonmalignant disease",
                                "requirement": {
                                    "requirement_type": "seriousness",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Serious uncontrolled nonmalignant disease (e.g., renal failure, liver failure, or other conditions)",
                                "criterion": "nonmalignant disease",
                                "requirement": {
                                    "requirement_type": "control status",
                                    "expected_value": "uncontrolled"
                                }
                            }
                        ]
                    },
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "renal failure",
                                "criterion": "renal failure",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "liver failure",
                                "criterion": "liver failure",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. History of autoimmune diseases requiring systemic immunosuppressive therapy in the last 2 years",
                "criterions": [
                    {
                        "exact_snippets": "History of autoimmune diseases",
                        "criterion": "autoimmune diseases",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "requiring systemic immunosuppressive therapy",
                        "criterion": "systemic immunosuppressive therapy",
                        "requirement": {
                            "requirement_type": "requirement for treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the last 2 years",
                        "criterion": "time since systemic immunosuppressive therapy",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "History of autoimmune diseases",
                        "criterion": "autoimmune diseases",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "requiring systemic immunosuppressive therapy",
                        "criterion": "systemic immunosuppressive therapy",
                        "requirement": {
                            "requirement_type": "requirement for treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the last 2 years",
                        "criterion": "time since systemic immunosuppressive therapy",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Known active infection with human immunodeficiency virus (HIV), human T-cell leukemia virus, type 1 (HTLV-1), hepatitis B virus (HBV), or hepatitis C virus (HCV)",
                "criterions": [
                    {
                        "exact_snippets": "Known active infection with human immunodeficiency virus (HIV)",
                        "criterion": "human immunodeficiency virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known active infection with ... human T-cell leukemia virus, type 1 (HTLV-1)",
                        "criterion": "human T-cell leukemia virus, type 1 (HTLV-1) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known active infection with ... hepatitis B virus (HBV)",
                        "criterion": "hepatitis B virus (HBV) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known active infection with ... hepatitis C virus (HCV)",
                        "criterion": "hepatitis C virus (HCV) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Known active infection with human immunodeficiency virus (HIV)",
                        "criterion": "human immunodeficiency virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known active infection with ... human T-cell leukemia virus, type 1 (HTLV-1)",
                        "criterion": "human T-cell leukemia virus, type 1 (HTLV-1) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known active infection with ... hepatitis B virus (HBV)",
                        "criterion": "hepatitis B virus (HBV) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Known active infection with ... hepatitis C virus (HCV)",
                        "criterion": "hepatitis C virus (HCV) infection",
                        "requirement": {
                            "requirement_type": "active infection",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "15. Active treatment with heparin or heparin-related therapies, unless the patient can be transitioned to a non-heparin treatment for the clinical condition with an adequate washout prior to enrollment in the study.",
                "criterions": [
                    {
                        "exact_snippets": "Active treatment with heparin or heparin-related therapies",
                        "criterion": "heparin or heparin-related therapy use",
                        "requirement": {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unless the patient can be transitioned to a non-heparin treatment for the clinical condition with an adequate washout prior to enrollment",
                        "criterion": "transition to non-heparin treatment with adequate washout",
                        "requirement": {
                            "requirement_type": "transition to non-heparin treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unless the patient can be transitioned to a non-heparin treatment for the clinical condition with an adequate washout prior to enrollment",
                        "criterion": "transition to non-heparin treatment with adequate washout",
                        "requirement": {
                            "requirement_type": "adequate washout prior to enrollment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "Active treatment with heparin or heparin-related therapies",
                    "criterion": "heparin or heparin-related therapy use",
                    "requirement": {
                        "requirement_type": "current use",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "and_criteria": [
                        {
                            "not_criteria": {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "unless the patient can be transitioned to a non-heparin treatment for the clinical condition with an adequate washout prior to enrollment",
                                        "criterion": "transition to non-heparin treatment with adequate washout",
                                        "requirement": {
                                            "requirement_type": "transition to non-heparin treatment",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "unless the patient can be transitioned to a non-heparin treatment for the clinical condition with an adequate washout prior to enrollment",
                                        "criterion": "transition to non-heparin treatment with adequate washout",
                                        "requirement": {
                                            "requirement_type": "adequate washout prior to enrollment",
                                            "expected_value": true
                                        }
                                    }
                                ]
                            }
                        }
                    ]
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "6. Conditions requiring systemic treatment with corticosteroids or any other form of immunosuppressive therapy within 7 days prior to start of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "Conditions requiring systemic treatment with corticosteroids ... within 7 days prior to start of study drug.",
                        "criterion": "systemic corticosteroid treatment",
                        "requirement": {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Conditions requiring systemic treatment with corticosteroids ... within 7 days prior to start of study drug.",
                        "criterion": "systemic corticosteroid treatment",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days prior to start of study drug"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Conditions requiring ... any other form of immunosuppressive therapy within 7 days prior to start of study drug.",
                        "criterion": "systemic immunosuppressive therapy (other than corticosteroids)",
                        "requirement": {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Conditions requiring ... any other form of immunosuppressive therapy within 7 days prior to start of study drug.",
                        "criterion": "systemic immunosuppressive therapy (other than corticosteroids)",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 7,
                                "unit": "days prior to start of study drug"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Conditions requiring systemic treatment with corticosteroids ... within 7 days prior to start of study drug.",
                                "criterion": "systemic corticosteroid treatment",
                                "requirement": {
                                    "requirement_type": "requirement",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Conditions requiring systemic treatment with corticosteroids ... within 7 days prior to start of study drug.",
                                "criterion": "systemic corticosteroid treatment",
                                "requirement": {
                                    "requirement_type": "time frame",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 7,
                                        "unit": "days prior to start of study drug"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Conditions requiring ... any other form of immunosuppressive therapy within 7 days prior to start of study drug.",
                                "criterion": "systemic immunosuppressive therapy (other than corticosteroids)",
                                "requirement": {
                                    "requirement_type": "requirement",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Conditions requiring ... any other form of immunosuppressive therapy within 7 days prior to start of study drug.",
                                "criterion": "systemic immunosuppressive therapy (other than corticosteroids)",
                                "requirement": {
                                    "requirement_type": "time frame",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 7,
                                        "unit": "days prior to start of study drug"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. History of prior organ transplant",
                "criterions": [
                    {
                        "exact_snippets": "History of prior organ transplant",
                        "criterion": "prior organ transplant",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "History of prior organ transplant",
                    "criterion": "prior organ transplant",
                    "requirement": {
                        "requirement_type": "history",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Patients with a history of hepatitis B or C are allowed if HBV DNA or HCV RNA are undetectable",
                "criterions": [
                    {
                        "exact_snippets": "history of hepatitis B or C",
                        "criterion": "history of hepatitis B or C",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "HBV DNA ... undetectable",
                        "criterion": "HBV DNA",
                        "requirement": {
                            "requirement_type": "detectability",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "HCV RNA ... undetectable",
                        "criterion": "HCV RNA",
                        "requirement": {
                            "requirement_type": "detectability",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "history of hepatitis B or C",
                    "criterion": "history of hepatitis B or C",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "and_criteria": [
                        {
                            "not_criteria": {
                                "exact_snippets": "HBV DNA ... undetectable",
                                "criterion": "HBV DNA",
                                "requirement": {
                                    "requirement_type": "detectability",
                                    "expected_value": false
                                }
                            }
                        },
                        {
                            "not_criteria": {
                                "exact_snippets": "HCV RNA ... undetectable",
                                "criterion": "HCV RNA",
                                "requirement": {
                                    "requirement_type": "detectability",
                                    "expected_value": false
                                }
                            }
                        }
                    ]
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "4. Known active brain metastases; patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks) and without the requirement for treatment with corticosteroids in prior 3 weeks may be considered for enrollment after discussion with the Medical Monitor",
                "criterions": [
                    {
                        "exact_snippets": "Known active brain metastases",
                        "criterion": "active brain metastases",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                        "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                        "requirement": {
                            "requirement_type": "treatment_status",
                            "expected_value": "previously treated"
                        }
                    },
                    {
                        "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                        "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                        "requirement": {
                            "requirement_type": "clinical_stability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                        "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                        "requirement": {
                            "requirement_type": "radiological_stability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                        "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                        "requirement": {
                            "requirement_type": "progression_free_interval",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without the requirement for treatment with corticosteroids in prior 3 weeks",
                        "criterion": "requirement for corticosteroid treatment",
                        "requirement": {
                            "requirement_type": "treatment_requirement",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "without the requirement for treatment with corticosteroids in prior 3 weeks",
                        "criterion": "requirement for corticosteroid treatment",
                        "requirement": {
                            "requirement_type": "time_window",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Known active brain metastases",
                        "criterion": "active brain metastases",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                                "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                                "requirement": {
                                    "requirement_type": "treatment_status",
                                    "expected_value": "previously treated"
                                }
                            },
                            {
                                "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                                "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                                "requirement": {
                                    "requirement_type": "clinical_stability",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                                "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                                "requirement": {
                                    "requirement_type": "radiological_stability",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "patients with previously treated, clinically stable, radiologically stable brain metastases (without evidence of progression in 4 weeks)",
                                "criterion": "brain metastases (previously treated, clinically and radiologically stable, no progression in 4 weeks)",
                                "requirement": {
                                    "requirement_type": "progression_free_interval",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "weeks"
                                    }
                                }
                            },
                            {
                                "or_criteria": [
                                    {
                                        "exact_snippets": "without the requirement for treatment with corticosteroids in prior 3 weeks",
                                        "criterion": "requirement for corticosteroid treatment",
                                        "requirement": {
                                            "requirement_type": "treatment_requirement",
                                            "expected_value": false
                                        }
                                    },
                                    {
                                        "exact_snippets": "without the requirement for treatment with corticosteroids in prior 3 weeks",
                                        "criterion": "requirement for corticosteroid treatment",
                                        "requirement": {
                                            "requirement_type": "time_window",
                                            "expected_value": {
                                                "operator": ">=",
                                                "value": 3,
                                                "unit": "weeks"
                                            }
                                        }
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. Pregnant or nursing women.",
                "criterions": [
                    {
                        "exact_snippets": "Pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "nursing women",
                        "criterion": "nursing status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "nursing women",
                        "criterion": "nursing status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Active, uncontrolled bacterial, viral, or fungal infections, requiring systemic therapy",
                "criterions": [
                    {
                        "exact_snippets": "Active, uncontrolled bacterial ... requiring systemic therapy",
                        "criterion": "bacterial infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled bacterial ... requiring systemic therapy",
                        "criterion": "bacterial infection",
                        "requirement": {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled bacterial ... requiring systemic therapy",
                        "criterion": "bacterial infection",
                        "requirement": {
                            "requirement_type": "treatment_requirement",
                            "expected_value": "requiring systemic therapy"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled ... viral ... requiring systemic therapy",
                        "criterion": "viral infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled ... viral ... requiring systemic therapy",
                        "criterion": "viral infection",
                        "requirement": {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled ... viral ... requiring systemic therapy",
                        "criterion": "viral infection",
                        "requirement": {
                            "requirement_type": "treatment_requirement",
                            "expected_value": "requiring systemic therapy"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled ... fungal ... requiring systemic therapy",
                        "criterion": "fungal infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled ... fungal ... requiring systemic therapy",
                        "criterion": "fungal infection",
                        "requirement": {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "Active, uncontrolled ... fungal ... requiring systemic therapy",
                        "criterion": "fungal infection",
                        "requirement": {
                            "requirement_type": "treatment_requirement",
                            "expected_value": "requiring systemic therapy"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Active, uncontrolled bacterial ... requiring systemic therapy",
                                "criterion": "bacterial infection",
                                "requirement": {
                                    "requirement_type": "activity",
                                    "expected_value": "active"
                                }
                            },
                            {
                                "exact_snippets": "Active, uncontrolled bacterial ... requiring systemic therapy",
                                "criterion": "bacterial infection",
                                "requirement": {
                                    "requirement_type": "control_status",
                                    "expected_value": "uncontrolled"
                                }
                            },
                            {
                                "exact_snippets": "Active, uncontrolled bacterial ... requiring systemic therapy",
                                "criterion": "bacterial infection",
                                "requirement": {
                                    "requirement_type": "treatment_requirement",
                                    "expected_value": "requiring systemic therapy"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Active, uncontrolled ... viral ... requiring systemic therapy",
                                "criterion": "viral infection",
                                "requirement": {
                                    "requirement_type": "activity",
                                    "expected_value": "active"
                                }
                            },
                            {
                                "exact_snippets": "Active, uncontrolled ... viral ... requiring systemic therapy",
                                "criterion": "viral infection",
                                "requirement": {
                                    "requirement_type": "control_status",
                                    "expected_value": "uncontrolled"
                                }
                            },
                            {
                                "exact_snippets": "Active, uncontrolled ... viral ... requiring systemic therapy",
                                "criterion": "viral infection",
                                "requirement": {
                                    "requirement_type": "treatment_requirement",
                                    "expected_value": "requiring systemic therapy"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Active, uncontrolled ... fungal ... requiring systemic therapy",
                                "criterion": "fungal infection",
                                "requirement": {
                                    "requirement_type": "activity",
                                    "expected_value": "active"
                                }
                            },
                            {
                                "exact_snippets": "Active, uncontrolled ... fungal ... requiring systemic therapy",
                                "criterion": "fungal infection",
                                "requirement": {
                                    "requirement_type": "control_status",
                                    "expected_value": "uncontrolled"
                                }
                            },
                            {
                                "exact_snippets": "Active, uncontrolled ... fungal ... requiring systemic therapy",
                                "criterion": "fungal infection",
                                "requirement": {
                                    "requirement_type": "treatment_requirement",
                                    "expected_value": "requiring systemic therapy"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Active infection with HIV and CD4+ T-cell count <350/μL. Patients not on established anti-retroviral therapy for at least 4 weeks and having a detectable HIV viral load",
                "criterions": [
                    {
                        "exact_snippets": "Active infection with HIV",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Active infection with HIV",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "CD4+ T-cell count <350/μL",
                        "criterion": "CD4+ T-cell count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 350,
                                "unit": "μL"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Patients not on established anti-retroviral therapy for at least 4 weeks",
                        "criterion": "anti-retroviral therapy duration",
                        "requirement": {
                            "requirement_type": "duration_on_therapy",
                            "expected_value": {
                                "operator": "<",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "having a detectable HIV viral load",
                        "criterion": "HIV viral load",
                        "requirement": {
                            "requirement_type": "detectability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Active infection with HIV",
                                "criterion": "HIV infection",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Active infection with HIV",
                                "criterion": "HIV infection",
                                "requirement": {
                                    "requirement_type": "activity",
                                    "expected_value": "active"
                                }
                            },
                            {
                                "exact_snippets": "CD4+ T-cell count <350/μL",
                                "criterion": "CD4+ T-cell count",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 350,
                                        "unit": "μL"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Patients not on established anti-retroviral therapy for at least 4 weeks",
                                "criterion": "anti-retroviral therapy duration",
                                "requirement": {
                                    "requirement_type": "duration_on_therapy",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 4,
                                        "unit": "weeks"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "having a detectable HIV viral load",
                                "criterion": "HIV viral load",
                                "requirement": {
                                    "requirement_type": "detectability",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "10. Unwillingness or inability to comply with procedures required in this protocol",
                "criterions": [
                    {
                        "exact_snippets": "Unwillingness ... to comply with procedures required in this protocol",
                        "criterion": "willingness to comply with protocol procedures",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "inability to comply with procedures required in this protocol",
                        "criterion": "ability to comply with protocol procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "not_criteria": {
                            "exact_snippets": "Unwillingness ... to comply with procedures required in this protocol",
                            "criterion": "willingness to comply with protocol procedures",
                            "requirement": {
                                "requirement_type": "willingness",
                                "expected_value": true
                            }
                        }
                    },
                    {
                        "not_criteria": {
                            "exact_snippets": "inability to comply with procedures required in this protocol",
                            "criterion": "ability to comply with protocol procedures",
                            "requirement": {
                                "requirement_type": "ability",
                                "expected_value": true
                            }
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "* Absolute neutrophil count ≥ 1500 cells/mm3",
                "criterions": [
                    {
                        "exact_snippets": "Absolute neutrophil count ≥ 1500 cells/mm3",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "cells/mm3"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute neutrophil count \u001e 1500 cells/mm3",
                        "criterion": "absolute neutrophil count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "cells/mm3"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Bilirubin ≤ 1.5 times upper limit of normal (ULN) or ≤ 5 × institutional ULN for patients who have serum bilirubin increases due to underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia).",
                "criterions": [
                    {
                        "exact_snippets": "Bilirubin ≤ 1.5 times upper limit of normal (ULN)",
                        "criterion": "bilirubin level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "times ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "≤ 5 × institutional ULN for patients who have serum bilirubin increases due to underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia)",
                        "criterion": "bilirubin level in patients with Gilbert's Syndrome",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "times institutional ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "≤ 5 × institutional ULN for patients who have serum bilirubin increases due to underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia)",
                        "criterion": "bilirubin level in patients with Gilbert's Syndrome",
                        "requirement": {
                            "requirement_type": "condition",
                            "expected_value": "underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia)"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Bilirubin \u00104 1.5 times upper limit of normal (ULN)",
                                "criterion": "bilirubin level",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 1.5,
                                        "unit": "times ULN"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "\u00104 5 \r institutional ULN for patients who have serum bilirubin increases due to underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia)",
                                "criterion": "bilirubin level in patients with Gilbert's Syndrome",
                                "requirement": {
                                    "requirement_type": "condition",
                                    "expected_value": "underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia)"
                                }
                            },
                            {
                                "exact_snippets": "\u00104 5 \r institutional ULN for patients who have serum bilirubin increases due to underlying Gilbert's Syndrome (familial benign unconjugated hyperbilirubinemia)",
                                "criterion": "bilirubin level in patients with Gilbert's Syndrome",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "times institutional ULN"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Advanced or metastatic tumors measurable per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria;",
                "criterions": [
                    {
                        "exact_snippets": "Advanced or metastatic tumors",
                        "criterion": "tumor stage",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "measurable per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria",
                        "criterion": "tumor measurability",
                        "requirement": {
                            "requirement_type": "measurability",
                            "expected_value": "measurable per RECIST 1.1"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "1. Histologically or cytologically confirmed advanced or metastatic solid tumors, for which no other standard treatment is available or appropriate, or for which the Trutino Biosciences Protocol #: TRT-ODC-IL2-001 Version: 1.0 Date: 20 September 2024 standard of care is refused by the patient due to tolerability or the Investigator believes the patient will not tolerate standard-of-care therapy",
                "criterions": [
                    {
                        "exact_snippets": "Histologically or cytologically confirmed advanced or metastatic solid tumors",
                        "criterion": "solid tumors",
                        "requirement": {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Histologically or cytologically confirmed advanced or metastatic solid tumors",
                        "criterion": "solid tumors",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "for which no other standard treatment is available or appropriate",
                        "criterion": "standard treatment availability or appropriateness",
                        "requirement": {
                            "requirement_type": "availability or appropriateness",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "standard of care is refused by the patient due to tolerability",
                        "criterion": "standard of care refusal",
                        "requirement": {
                            "requirement_type": "refusal by patient",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "standard of care is refused by the patient due to tolerability",
                        "criterion": "standard of care refusal",
                        "requirement": {
                            "requirement_type": "reason for refusal",
                            "expected_value": "tolerability"
                        }
                    },
                    {
                        "exact_snippets": "the Investigator believes the patient will not tolerate standard-of-care therapy",
                        "criterion": "investigator assessment of standard-of-care tolerability",
                        "requirement": {
                            "requirement_type": "investigator assessment of tolerability",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "• Calculated creatinine clearance ≥ 50 mL/min using the Cockcroft-Gault equation.",
                "criterions": [
                    {
                        "exact_snippets": "Calculated creatinine clearance ≥ 50 mL/min using the Cockcroft-Gault equation.",
                        "criterion": "creatinine clearance",
                        "requirement": {
                            "requirement_type": "calculation method",
                            "expected_value": "Cockcroft-Gault equation"
                        }
                    },
                    {
                        "exact_snippets": "Calculated creatinine clearance ≥ 50 mL/min using the Cockcroft-Gault equation.",
                        "criterion": "creatinine clearance",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "mL/min"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Calculated creatinine clearance \u001e 50 mL/min using the Cockcroft-Gault equation.",
                        "criterion": "creatinine clearance",
                        "requirement": {
                            "requirement_type": "calculation method",
                            "expected_value": "Cockcroft-Gault equation"
                        }
                    },
                    {
                        "exact_snippets": "Calculated creatinine clearance \u001e 50 mL/min using the Cockcroft-Gault equation.",
                        "criterion": "creatinine clearance",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "mL/min"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Age ≥ 18 years;",
                "criterions": [
                    {
                        "exact_snippets": "Age ≥ 18 years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Age  18 years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Hemoglobin ≥ 9 g/dL",
                "criterions": [
                    {
                        "exact_snippets": "Hemoglobin ≥ 9 g/dL",
                        "criterion": "hemoglobin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Hemoglobin \u0013e 9 g/dL",
                        "criterion": "hemoglobin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                "criterions": [
                    {
                        "exact_snippets": "Aspartate aminotransferase (AST) ... ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                        "criterion": "aspartate aminotransferase (AST) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2.5,
                                        "unit": "x ULN"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Aspartate aminotransferase (AST) ... ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                        "criterion": "aspartate aminotransferase (AST) level",
                        "requirement": {
                            "requirement_type": "quantity (with liver metastases)",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "x ULN"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "alanine aminotransferase (ALT) ... ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                        "criterion": "alanine aminotransferase (ALT) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2.5,
                                        "unit": "x ULN"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "alanine aminotransferase (ALT) ... ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                        "criterion": "alanine aminotransferase (ALT) level",
                        "requirement": {
                            "requirement_type": "quantity (with liver metastases)",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "x ULN"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "alkaline phosphatase ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                        "criterion": "alkaline phosphatase level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2.5,
                                        "unit": "x ULN"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "alkaline phosphatase ≤ 2.5 x ULN (if liver metastases are present, then ≤ 5 x ULN is allowed)",
                        "criterion": "alkaline phosphatase level",
                        "requirement": {
                            "requirement_type": "quantity (with liver metastases)",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "x ULN"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "or_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Aspartate aminotransferase (AST) ... \u00103 2.5 x ULN (if liver metastases are present, then \u00103 5 x ULN is allowed)",
                                        "criterion": "aspartate aminotransferase (AST) level",
                                        "requirement": {
                                            "requirement_type": "quantity",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 2.5,
                                                        "unit": "x ULN"
                                                    }
                                                ]
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "alanine aminotransferase (ALT) ... \u00103 2.5 x ULN (if liver metastases are present, then \u00103 5 x ULN is allowed)",
                                        "criterion": "alanine aminotransferase (ALT) level",
                                        "requirement": {
                                            "requirement_type": "quantity",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 2.5,
                                                        "unit": "x ULN"
                                                    }
                                                ]
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "alkaline phosphatase \u00103 2.5 x ULN (if liver metastases are present, then \u00103 5 x ULN is allowed)",
                                        "criterion": "alkaline phosphatase level",
                                        "requirement": {
                                            "requirement_type": "quantity",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 2.5,
                                                        "unit": "x ULN"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Aspartate aminotransferase (AST) ... \u00103 2.5 x ULN (if liver metastases are present, then \u00103 5 x ULN is allowed)",
                                        "criterion": "aspartate aminotransferase (AST) level",
                                        "requirement": {
                                            "requirement_type": "quantity (with liver metastases)",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 5,
                                                        "unit": "x ULN"
                                                    }
                                                ]
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "alanine aminotransferase (ALT) ... \u00103 2.5 x ULN (if liver metastases are present, then \u00103 5 x ULN is allowed)",
                                        "criterion": "alanine aminotransferase (ALT) level",
                                        "requirement": {
                                            "requirement_type": "quantity (with liver metastases)",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 5,
                                                        "unit": "x ULN"
                                                    }
                                                ]
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "alkaline phosphatase \u00103 2.5 x ULN (if liver metastases are present, then \u00103 5 x ULN is allowed)",
                                        "criterion": "alkaline phosphatase level",
                                        "requirement": {
                                            "requirement_type": "quantity (with liver metastases)",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 5,
                                                        "unit": "x ULN"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Platelet count ≥ 75,000 (plt/mm3)",
                "criterions": [
                    {
                        "exact_snippets": "Platelet count ≥ 75,000 (plt/mm3)",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 75000,
                                "unit": "plt/mm3"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Platelet count \u001e 75,000 (plt/mm3)",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 75000,
                                "unit": "plt/mm3"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Women of childbearing potential (WOCBP) and men with WOCBP partners must agree to use adequate contraception (hormonal method of birth control; intrauterine devices or abstinence) prior to study entry, for the duration of study participation and for 4 months after the last dose of study drug. Should a female trial participant or a female partner of a male trial participant become pregnant or suspect she is pregnant during the study, the Investigator must be informed immediately.",
                "criterions": [
                    {
                        "exact_snippets": "Women of childbearing potential (WOCBP) and men with WOCBP partners must agree to use adequate contraception (hormonal method of birth control; intrauterine devices or abstinence) prior to study entry, for the duration of study participation and for 4 months after the last dose of study drug.",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Women of childbearing potential (WOCBP) and men with WOCBP partners must agree to use adequate contraception (hormonal method of birth control; intrauterine devices or abstinence) prior to study entry, for the duration of study participation and for 4 months after the last dose of study drug.",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": [
                                "hormonal method of birth control",
                                "intrauterine devices",
                                "abstinence"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Women of childbearing potential (WOCBP) and men with WOCBP partners must agree to use adequate contraception (hormonal method of birth control; intrauterine devices or abstinence) prior to study entry, for the duration of study participation and for 4 months after the last dose of study drug.",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": "prior to study entry, for the duration of study participation and for 4 months after the last dose of study drug"
                        }
                    },
                    {
                        "exact_snippets": "Women of childbearing potential (WOCBP)",
                        "criterion": "women of childbearing potential status",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "men with WOCBP partners",
                        "criterion": "male participant with WOCBP partner",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "1. New York Heart Association Class III or IV, cardiac disease, myocardial infarction within the past 6 months, unstable arrhythmia, or evidence of ischemia on electrocardiogram (ECG)",
                "criterions": [
                    {
                        "exact_snippets": "New York Heart Association Class III or IV",
                        "criterion": "New York Heart Association (NYHA) class",
                        "requirement": {
                            "requirement_type": "classification",
                            "expected_value": [
                                "III",
                                "IV"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "cardiac disease",
                        "criterion": "cardiac disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "myocardial infarction within the past 6 months",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "unstable arrhythmia",
                        "criterion": "unstable arrhythmia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "evidence of ischemia on electrocardiogram (ECG)",
                        "criterion": "ischemia on electrocardiogram (ECG)",
                        "requirement": {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "9. Treatment with radiation therapy, major surgery, chemotherapy, or investigational therapy within 4 weeks prior to study entry (6 weeks for nitrosoureas or mitomycin C). Radiation for palliation of pain is allowed within 1 week prior to study entry, but the lesion should not be selected as a target lesion for RECIST analysis.",
                "criterions": [
                    {
                        "exact_snippets": "Treatment with radiation therapy, major surgery, chemotherapy, or investigational therapy within 4 weeks prior to study entry (6 weeks for nitrosoureas or mitomycin C)",
                        "criterion": "recent cancer treatment",
                        "requirement": {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "radiation therapy",
                                "major surgery",
                                "chemotherapy",
                                "investigational therapy"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Treatment with radiation therapy, major surgery, chemotherapy, or investigational therapy within 4 weeks prior to study entry (6 weeks for nitrosoureas or mitomycin C)",
                        "criterion": "recent cancer treatment",
                        "requirement": {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "weeks"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Treatment with radiation therapy, major surgery, chemotherapy, or investigational therapy within 4 weeks prior to study entry (6 weeks for nitrosoureas or mitomycin C)",
                        "criterion": "recent cancer treatment",
                        "requirement": {
                            "requirement_type": "time since nitrosoureas or mitomycin C",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 6,
                                        "unit": "weeks"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Radiation for palliation of pain is allowed within 1 week prior to study entry",
                        "criterion": "palliative radiation for pain",
                        "requirement": {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "week"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Radiation for palliation of pain is allowed within 1 week prior to study entry",
                        "criterion": "palliative radiation for pain",
                        "requirement": {
                            "requirement_type": "allowance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "the lesion should not be selected as a target lesion for RECIST analysis",
                        "criterion": "lesion treated with palliative radiation",
                        "requirement": {
                            "requirement_type": "selection as RECIST target lesion",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "13. Prior treatment with an IL-2 targeted treatment, unless given as a part of a tumor infiltrating lymphocyte treatment combination;",
                "criterions": [
                    {
                        "exact_snippets": "Prior treatment with an IL-2 targeted treatment, unless given as a part of a tumor infiltrating lymphocyte treatment combination",
                        "criterion": "prior IL-2 targeted treatment",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Prior treatment with an IL-2 targeted treatment, unless given as a part of a tumor infiltrating lymphocyte treatment combination",
                        "criterion": "prior IL-2 targeted treatment",
                        "requirement": {
                            "requirement_type": "exception",
                            "expected_value": "allowed if given as part of a tumor infiltrating lymphocyte treatment combination"
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "Prior treatment with an IL-2 targeted treatment, unless given as a part of a tumor infiltrating lymphocyte treatment combination",
                    "criterion": "prior IL-2 targeted treatment",
                    "requirement": {
                        "requirement_type": "history of treatment",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "not_criteria": {
                        "exact_snippets": "Prior treatment with an IL-2 targeted treatment, unless given as a part of a tumor infiltrating lymphocyte treatment combination",
                        "criterion": "prior IL-2 targeted treatment",
                        "requirement": {
                            "requirement_type": "exception",
                            "expected_value": "allowed if given as part of a tumor infiltrating lymphocyte treatment combination"
                        }
                    }
                },
                "else_criteria": null
            }
        }
    ],
    "failed_miscellaneous": []
}